Mycobacterial infection: A difficult and late diagnosis in stem cell transplant recipients

C. Cordonnier, R. Martino, P. Trabasso, T. K. Held, H. Akan, M. S. Ward, K. Fabian, A. J. Ullmann, N. Wulffraat, P. Ljungman, E. P. Alessandrino, J. Pretnar, J. Gmür, R. Varela, A. Vitek, S. Sica, M. Rovira

Research output: Contribution to journalArticlepeer-review


The Infectious Diseases Working Party of the European Blood and Marrow Transplant Group conducted a survey to obtain information about the frequency, presentation, and treatment of mycobacterial infection (MBI) in stem cell transplant (SCT) recipients. Among 29 centers, MBI was diagnosed in 0.79% of 1513 allogeneic and 0.23% of 3012 autologous SCT recipients during 1994-1998 a median of 160 days after transplantation. The mean interval between first symptoms and diagnosis was 29 days and was still longer for patients with atypical MBI or recipients of corticosteroid therapy. The prevalence of MBI was highest among those who received matched unrelated or mismatched STCs from related donors. Of 31 patients, 20 had tuberculosis, 8 had atypical MBI, and 3 had diagnoses based on histological findings only. Five patients (16%) died, all of whom had received an allogeneic SCT. Because of the increased numbers of unmatched donors and transplantation programs in countries with a high prevalence of tuberculosis, constant vigilance is required to early detect MBI in SCT recipients.

Original languageEnglish
Pages (from-to)1229-1236
Number of pages8
JournalClinical Infectious Diseases
Issue number9
Publication statusPublished - May 1 2004

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Mycobacterial infection: A difficult and late diagnosis in stem cell transplant recipients'. Together they form a unique fingerprint.

Cite this